|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14,380.00 GBX | +0.11% |
|
-0.83% | +4.28% |
| 12/03 | European Markets in the Red as Concerns Persist |  |
| 12/03 | Abivax Denies Reported Takeover Talks With AstraZeneca | MT |
| Capitalization | 30TCr 26TCr 24TCr 22TCr 41TCr 27,54400Cr 43TCr 2,80900Cr 1,11300Cr 13,15900Cr 1,11700Cr 1,09400Cr 47,53000Cr | P/E ratio 2026 * |
24.1x | P/E ratio 2027 * | 21.2x |
|---|---|---|---|---|---|
| Enterprise value | 32TCr 28TCr 25TCr 24TCr 43TCr 29,23900Cr 45TCr 2,98200Cr 1,18200Cr 13,96900Cr 1,18600Cr 1,16100Cr 50,45300Cr | EV / Sales 2026 * |
5.03x | EV / Sales 2027 * | 4.61x |
| Free-Float |
96.62% | Yield 2026 * |
1.73% | Yield 2027 * | 1.84% |
Last Transcript: AstraZeneca PLC
| 1 day | -0.21% | ||
| 1 week | -0.83% | ||
| Current month | -7.48% | ||
| 1 month | -4.88% | ||
| 3 months | +5.64% | ||
| 6 months | +25.99% | ||
| Current year | +4.28% |
| 1 week | 14,015.91 |  | 14,790 |
| 1 month | 14,015.91 | | 15,732 |
| Current year | 13,268 | | 15,732 |
| 1 year | 9,573.5 | | 15,732 |
| 3 years | 9,461 | | 15,732 |
| 5 years | 6,899.8 | | 15,732 |
| 10 years | 3,680 | | 15,732 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Soriot
CEO | Chief Executive Officer | 65 | 01/10/2012 |
Aradhana Sarin
DFI | Director of Finance/CFO | 52 | 01/08/2021 |
Sharon Barr
CTO | Chief Tech/Sci/R&D Officer | - | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 06/04/1999 | |
Pascal Soriot
BRD | Director/Board Member | 65 | 01/10/2012 |
Philip Broadley
BRD | Director/Board Member | 65 | 27/04/2017 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +3.29% | 8.29% | 64 M€ | |
| -1.51% | 5.39% | 1,387 M€ | |
| -3.15% | 5.17% | 26 M€ | |
| +3.99% | 4.89% | 1,127 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.11% | -0.83% | +21.02% | +34.57% | 30TCr | |
| +1.41% | -0.52% | +22.90% | +203.61% | 87TCr | |
| +0.07% | +0.68% | +48.50% | +58.13% | 58TCr | |
| -2.31% | -4.45% | +3.93% | +44.70% | 40TCr | |
| +0.79% | -6.01% | +5.81% | +21.36% | 32TCr | |
| +0.43% | -1.54% | +25.20% | +62.42% | 29TCr | |
| -0.54% | +0.13% | +22.42% | +9.66% | 29TCr | |
| +0.06% | -0.79% | +17.26% | +57.22% | 20TCr | |
| +0.66% | +0.48% | +27.59% | +81.89% | 18TCr | |
| -0.91% | -1.50% | +4.08% | -33.15% | 15TCr | |
| Average | -0.10% | -1.71% | +19.87% | +54.04% | 35.88TCr | |
| Weighted average by Cap. | +0.10% | -1.63% | +22.53% | +80.50% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.28TCr 5.49TCr 4.96TCr 4.75TCr 8.63TCr 5,81000Cr 8.97TCr 59TCr 23TCr 2,77600Cr 24TCr 23TCr 10,02500Cr | 6.68TCr 5.84TCr 5.28TCr 5.05TCr 9.18TCr 6,18000Cr 9.54TCr 63TCr 25TCr 2,95300Cr 25TCr 25TCr 10,66500Cr |
| Net income | 1.25TCr 1.09TCr 987.57Cr 944.73Cr 1.72TCr 1,15700Cr 1.79TCr 12TCr 4.68TCr 55TCr 4.69TCr 4.59TCr 1,99600Cr | 1.42TCr 1.24TCr 1.12TCr 1.07TCr 1.95TCr 1,31200Cr 2.03TCr 13TCr 5.3TCr 63TCr 5.32TCr 5.21TCr 2,26300Cr |
| Net Debt | 1.83TCr 1.6TCr 1.45TCr 1.38TCr 2.52TCr 1,69400Cr 2.62TCr 17TCr 6.85TCr 81TCr 6.87TCr 6.73TCr 2,92400Cr | 1.03TCr 897.12Cr 810.5Cr 775.34Cr 1.41TCr 95TCr 1.47TCr 9.68TCr 3.84TCr 45TCr 3.85TCr 3.77TCr 1,63800Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 14,380.00 p | +0.11% | 11,99,357 |
| 12/26/12 | 14,364.00 p | -0.83% | 28,87,894 |
| 11/26/11 | 14,484.00 p | -1.16% | 43,82,544 |
| 10/26/10 | 14,654.00 p | +1.47% | 31,82,286 |
| 09/26/09 | 14,442.00 p | -0.40% | 30,31,335 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AZN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition